Stock listing

Cosciens Biopharma Inc.

Selected listing: A40J1L · LS · EUR · DE

Cosciens Biopharma Inc. (Lang & Schwarz: A40J1L), Health Technology. Latest release Sep 16, 2026: COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE…

A40J1L:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A40J1L
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Cosciens Biopharma Inc.

COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING

September 16, 2026

Canadian Investment Regulatory Organization Trade Resumption - CSCI

September 11, 2026

COSCIENS ACQUIRES NUALTIS CORP.

September 10, 2026

COSCIENS Biopharma Inc. Reports Q2 2026 Results

August 11, 2026

COSCIENS Biopharma Inc. Completes Share Capital Amendment

July 3, 2026

All Cosciens Biopharma Inc. news →

Research Cosciens Biopharma Inc.

Cosciens Biopharma Inc. company profile

View the public company page for Cosciens Biopharma Inc. on 6ix.

Cosciens Biopharma Inc. news

Read company news and market updates connected to Cosciens Biopharma Inc..

Cosciens Biopharma Inc. investor events

Find investor webinars, events, and replay context for Cosciens Biopharma Inc..